Questões de Concurso Sobre inglês

Foram encontradas 25.700 questões

Resolva questões gratuitamente!

Junte-se a mais de 4 milhões de concurseiros!

Q3669785 Inglês
Dialogue:
Karen: Have you heard about the new art exhibition at the downtown gallery?
Bruce: Yes, I have. I heard it features works from artists around the world. I'm planning to go this weekend.
Karen: That sounds amazing! I heard they're showcasing a diverse range of artistic styles and cultural influences.
Based on the conversation, what can be inferred about Bruce's attitude towards the art exhibition? 
Alternativas
Q3669784 Inglês
You are writing an email to your friend describing a recent experience at a local farmers' market. Which of the following sentences would be the most appropriate opening line for your email, engaging your friend's interest in your experience?
Alternativas
Q3669778 Inglês
Dialogue:
Susan: Hey, have you seen my keys? I can't find them anywhere!
Patrick: Did you check the living room? You might have left them there last night.
Susan: Oh, you're right! I just found them behind the couch. Thanks!
Which phrasal verb in the dialogue means "to discover" or "to locate something that was lost"? 
Alternativas
Q3669777 Inglês
You are tasked with writing an abstract for a research paper on renewable energy sources. Which of the following options represents an effective abstract, summarizing the key points of your research concisely and clearly? 
Alternativas
Q3669693 Inglês

Complete the dialogue with the appropriate comparative form:



A: This book is interesting, but the sequel is_____.


B: Really? I didn't know that. I'll have to read it.

Alternativas
Q3669691 Inglês
Identify the sentence with the correct transformation from direct to indirect speech:
Alternativas
Q3669690 Inglês
Complete the dialogue with the correct use of numerals and nominal groups, respectively:

A: How____have you visited so far?
B: I have been to____countries. My goal is to visit at least____more next year.
Alternativas
Q3669689 Inglês
Identify the sentence with a causative verb form:
Alternativas
Q3669688 Inglês
O texto seguinte servirá de base para responder à questão.


CANCER PILL HOPE NHS to offer 300,000 women at high risk of breast cancer a 4p pill that could halve danger


(1º§) Once-a-day tumour drug Anastrozole is to be repurposed as a preventative after research showed it slashed the threat by 49 per cent. The NHS in England will offer it to around 289,000 post-menopausal women who have genes that mean breast cancer runs in their family. It estimates 2,000 cancers could be prevented for every 36,000 women who take the drug for five years. 

(2º§) Doctors have been allowed to prescribe Anastrozole, also known as Arimidex, to prevent cancer since 2017 but it was never officially designated for this purpose, so was uncommon. A new licence from the Medicines and Healthcare products Regulatory Agency means it will now become standard care. The hormone therapy reduces ­levels of oestrogen that some tumours feed off.

(3º§) NHS England chief exec Amanda Pritchard said: "This is the first drug to be repurposed through a world-leading new programme to help us realise the full potential of existing medicines to save and improve lives." Baroness Delyth Morgan, of charity Breast Cancer Now, called the roll-out a "major step forward". Baroness Delyth Morgan, chief executive at the charity Breast Cancer Now, said: "[It] will enable more eligible women with a significant family history of breast cancer to reduce their chance of developing the disease." The treatment is taken as a 1mg tablet, once a day for five years.

(4º§) Trials have shown that the drug reduces breast cancer cases by 49 per cent over 11 years among eligible women. The most common side effects of the medicine are hot flushes, feeling weak, pain/stiffness in the joints, arthritis, skin rash, nausea, headache, osteoporosis, and depression. The cases prevented by anastrozole could save the NHS £15 million in treatment costs.

(5º§) Around 47,000 women in England are diagnosed with breast cancer each year. Health Minister Will Quince said: "Breast cancer is the most common cancer in the UK so I'm delighted that another effective drug to help to prevent this cruel disease has now been approved. "We've already seen the positive effect anastrozole can have in treating the disease when it has been detected in post-menopausal women and now we can use it to stop it developing at all in some women." 


https://www.thesun.co.uk/health/24652823/nhs-offer-anastrozole-breast -cancer/ 
According to the information provided, what is the significance of the new license obtained by Anastrozole (Arimidex) from the Medicines and Healthcare products Regulatory Agency?
Alternativas
Q3669687 Inglês
O texto seguinte servirá de base para responder à questão.


CANCER PILL HOPE NHS to offer 300,000 women at high risk of breast cancer a 4p pill that could halve danger


(1º§) Once-a-day tumour drug Anastrozole is to be repurposed as a preventative after research showed it slashed the threat by 49 per cent. The NHS in England will offer it to around 289,000 post-menopausal women who have genes that mean breast cancer runs in their family. It estimates 2,000 cancers could be prevented for every 36,000 women who take the drug for five years. 

(2º§) Doctors have been allowed to prescribe Anastrozole, also known as Arimidex, to prevent cancer since 2017 but it was never officially designated for this purpose, so was uncommon. A new licence from the Medicines and Healthcare products Regulatory Agency means it will now become standard care. The hormone therapy reduces ­levels of oestrogen that some tumours feed off.

(3º§) NHS England chief exec Amanda Pritchard said: "This is the first drug to be repurposed through a world-leading new programme to help us realise the full potential of existing medicines to save and improve lives." Baroness Delyth Morgan, of charity Breast Cancer Now, called the roll-out a "major step forward". Baroness Delyth Morgan, chief executive at the charity Breast Cancer Now, said: "[It] will enable more eligible women with a significant family history of breast cancer to reduce their chance of developing the disease." The treatment is taken as a 1mg tablet, once a day for five years.

(4º§) Trials have shown that the drug reduces breast cancer cases by 49 per cent over 11 years among eligible women. The most common side effects of the medicine are hot flushes, feeling weak, pain/stiffness in the joints, arthritis, skin rash, nausea, headache, osteoporosis, and depression. The cases prevented by anastrozole could save the NHS £15 million in treatment costs.

(5º§) Around 47,000 women in England are diagnosed with breast cancer each year. Health Minister Will Quince said: "Breast cancer is the most common cancer in the UK so I'm delighted that another effective drug to help to prevent this cruel disease has now been approved. "We've already seen the positive effect anastrozole can have in treating the disease when it has been detected in post-menopausal women and now we can use it to stop it developing at all in some women." 


https://www.thesun.co.uk/health/24652823/nhs-offer-anastrozole-breast -cancer/ 
What is the antecedent of the pronoun "it" in the sentence "We've already seen the positive effect anastrozole can have in treating the disease when it has been detected in post-menopausal women" (5º§)?
Alternativas
Q3669686 Inglês
O texto seguinte servirá de base para responder à questão.


CANCER PILL HOPE NHS to offer 300,000 women at high risk of breast cancer a 4p pill that could halve danger


(1º§) Once-a-day tumour drug Anastrozole is to be repurposed as a preventative after research showed it slashed the threat by 49 per cent. The NHS in England will offer it to around 289,000 post-menopausal women who have genes that mean breast cancer runs in their family. It estimates 2,000 cancers could be prevented for every 36,000 women who take the drug for five years. 

(2º§) Doctors have been allowed to prescribe Anastrozole, also known as Arimidex, to prevent cancer since 2017 but it was never officially designated for this purpose, so was uncommon. A new licence from the Medicines and Healthcare products Regulatory Agency means it will now become standard care. The hormone therapy reduces ­levels of oestrogen that some tumours feed off.

(3º§) NHS England chief exec Amanda Pritchard said: "This is the first drug to be repurposed through a world-leading new programme to help us realise the full potential of existing medicines to save and improve lives." Baroness Delyth Morgan, of charity Breast Cancer Now, called the roll-out a "major step forward". Baroness Delyth Morgan, chief executive at the charity Breast Cancer Now, said: "[It] will enable more eligible women with a significant family history of breast cancer to reduce their chance of developing the disease." The treatment is taken as a 1mg tablet, once a day for five years.

(4º§) Trials have shown that the drug reduces breast cancer cases by 49 per cent over 11 years among eligible women. The most common side effects of the medicine are hot flushes, feeling weak, pain/stiffness in the joints, arthritis, skin rash, nausea, headache, osteoporosis, and depression. The cases prevented by anastrozole could save the NHS £15 million in treatment costs.

(5º§) Around 47,000 women in England are diagnosed with breast cancer each year. Health Minister Will Quince said: "Breast cancer is the most common cancer in the UK so I'm delighted that another effective drug to help to prevent this cruel disease has now been approved. "We've already seen the positive effect anastrozole can have in treating the disease when it has been detected in post-menopausal women and now we can use it to stop it developing at all in some women." 


https://www.thesun.co.uk/health/24652823/nhs-offer-anastrozole-breast -cancer/ 
According to the text, what impact does the widespread use of Anastrozole have on the healthcare system?
Alternativas
Q3669685 Inglês
O texto seguinte servirá de base para responder à questão.


CANCER PILL HOPE NHS to offer 300,000 women at high risk of breast cancer a 4p pill that could halve danger


(1º§) Once-a-day tumour drug Anastrozole is to be repurposed as a preventative after research showed it slashed the threat by 49 per cent. The NHS in England will offer it to around 289,000 post-menopausal women who have genes that mean breast cancer runs in their family. It estimates 2,000 cancers could be prevented for every 36,000 women who take the drug for five years. 

(2º§) Doctors have been allowed to prescribe Anastrozole, also known as Arimidex, to prevent cancer since 2017 but it was never officially designated for this purpose, so was uncommon. A new licence from the Medicines and Healthcare products Regulatory Agency means it will now become standard care. The hormone therapy reduces ­levels of oestrogen that some tumours feed off.

(3º§) NHS England chief exec Amanda Pritchard said: "This is the first drug to be repurposed through a world-leading new programme to help us realise the full potential of existing medicines to save and improve lives." Baroness Delyth Morgan, of charity Breast Cancer Now, called the roll-out a "major step forward". Baroness Delyth Morgan, chief executive at the charity Breast Cancer Now, said: "[It] will enable more eligible women with a significant family history of breast cancer to reduce their chance of developing the disease." The treatment is taken as a 1mg tablet, once a day for five years.

(4º§) Trials have shown that the drug reduces breast cancer cases by 49 per cent over 11 years among eligible women. The most common side effects of the medicine are hot flushes, feeling weak, pain/stiffness in the joints, arthritis, skin rash, nausea, headache, osteoporosis, and depression. The cases prevented by anastrozole could save the NHS £15 million in treatment costs.

(5º§) Around 47,000 women in England are diagnosed with breast cancer each year. Health Minister Will Quince said: "Breast cancer is the most common cancer in the UK so I'm delighted that another effective drug to help to prevent this cruel disease has now been approved. "We've already seen the positive effect anastrozole can have in treating the disease when it has been detected in post-menopausal women and now we can use it to stop it developing at all in some women." 


https://www.thesun.co.uk/health/24652823/nhs-offer-anastrozole-breast -cancer/ 
Select the alternative that presents an uncountable noun:
Alternativas
Q3669684 Inglês
O texto seguinte servirá de base para responder à questão.


CANCER PILL HOPE NHS to offer 300,000 women at high risk of breast cancer a 4p pill that could halve danger


(1º§) Once-a-day tumour drug Anastrozole is to be repurposed as a preventative after research showed it slashed the threat by 49 per cent. The NHS in England will offer it to around 289,000 post-menopausal women who have genes that mean breast cancer runs in their family. It estimates 2,000 cancers could be prevented for every 36,000 women who take the drug for five years. 

(2º§) Doctors have been allowed to prescribe Anastrozole, also known as Arimidex, to prevent cancer since 2017 but it was never officially designated for this purpose, so was uncommon. A new licence from the Medicines and Healthcare products Regulatory Agency means it will now become standard care. The hormone therapy reduces ­levels of oestrogen that some tumours feed off.

(3º§) NHS England chief exec Amanda Pritchard said: "This is the first drug to be repurposed through a world-leading new programme to help us realise the full potential of existing medicines to save and improve lives." Baroness Delyth Morgan, of charity Breast Cancer Now, called the roll-out a "major step forward". Baroness Delyth Morgan, chief executive at the charity Breast Cancer Now, said: "[It] will enable more eligible women with a significant family history of breast cancer to reduce their chance of developing the disease." The treatment is taken as a 1mg tablet, once a day for five years.

(4º§) Trials have shown that the drug reduces breast cancer cases by 49 per cent over 11 years among eligible women. The most common side effects of the medicine are hot flushes, feeling weak, pain/stiffness in the joints, arthritis, skin rash, nausea, headache, osteoporosis, and depression. The cases prevented by anastrozole could save the NHS £15 million in treatment costs.

(5º§) Around 47,000 women in England are diagnosed with breast cancer each year. Health Minister Will Quince said: "Breast cancer is the most common cancer in the UK so I'm delighted that another effective drug to help to prevent this cruel disease has now been approved. "We've already seen the positive effect anastrozole can have in treating the disease when it has been detected in post-menopausal women and now we can use it to stop it developing at all in some women." 


https://www.thesun.co.uk/health/24652823/nhs-offer-anastrozole-breast -cancer/ 
Here you have some translations:

I. Run in: Auxiliar na (1º§).
II. Offer it to: Oferecer a (1º§).
III. Feed off: Se alimentam de (2º§).
IV. Slashed the threat by: Reduziu a ameaça em (1º§).
V. Developing at all: Desenvolver de forma alguma (5º§).

We have correct translations in:
Alternativas
Q3669683 Inglês
O texto seguinte servirá de base para responder à questão.


CANCER PILL HOPE NHS to offer 300,000 women at high risk of breast cancer a 4p pill that could halve danger


(1º§) Once-a-day tumour drug Anastrozole is to be repurposed as a preventative after research showed it slashed the threat by 49 per cent. The NHS in England will offer it to around 289,000 post-menopausal women who have genes that mean breast cancer runs in their family. It estimates 2,000 cancers could be prevented for every 36,000 women who take the drug for five years. 

(2º§) Doctors have been allowed to prescribe Anastrozole, also known as Arimidex, to prevent cancer since 2017 but it was never officially designated for this purpose, so was uncommon. A new licence from the Medicines and Healthcare products Regulatory Agency means it will now become standard care. The hormone therapy reduces ­levels of oestrogen that some tumours feed off.

(3º§) NHS England chief exec Amanda Pritchard said: "This is the first drug to be repurposed through a world-leading new programme to help us realise the full potential of existing medicines to save and improve lives." Baroness Delyth Morgan, of charity Breast Cancer Now, called the roll-out a "major step forward". Baroness Delyth Morgan, chief executive at the charity Breast Cancer Now, said: "[It] will enable more eligible women with a significant family history of breast cancer to reduce their chance of developing the disease." The treatment is taken as a 1mg tablet, once a day for five years.

(4º§) Trials have shown that the drug reduces breast cancer cases by 49 per cent over 11 years among eligible women. The most common side effects of the medicine are hot flushes, feeling weak, pain/stiffness in the joints, arthritis, skin rash, nausea, headache, osteoporosis, and depression. The cases prevented by anastrozole could save the NHS £15 million in treatment costs.

(5º§) Around 47,000 women in England are diagnosed with breast cancer each year. Health Minister Will Quince said: "Breast cancer is the most common cancer in the UK so I'm delighted that another effective drug to help to prevent this cruel disease has now been approved. "We've already seen the positive effect anastrozole can have in treating the disease when it has been detected in post-menopausal women and now we can use it to stop it developing at all in some women." 


https://www.thesun.co.uk/health/24652823/nhs-offer-anastrozole-breast -cancer/ 
Select the alternative that presents a sentence in Present Perfect Tense:
Alternativas
Q3669682 Inglês
O texto seguinte servirá de base para responder à questão.


CANCER PILL HOPE NHS to offer 300,000 women at high risk of breast cancer a 4p pill that could halve danger


(1º§) Once-a-day tumour drug Anastrozole is to be repurposed as a preventative after research showed it slashed the threat by 49 per cent. The NHS in England will offer it to around 289,000 post-menopausal women who have genes that mean breast cancer runs in their family. It estimates 2,000 cancers could be prevented for every 36,000 women who take the drug for five years. 

(2º§) Doctors have been allowed to prescribe Anastrozole, also known as Arimidex, to prevent cancer since 2017 but it was never officially designated for this purpose, so was uncommon. A new licence from the Medicines and Healthcare products Regulatory Agency means it will now become standard care. The hormone therapy reduces ­levels of oestrogen that some tumours feed off.

(3º§) NHS England chief exec Amanda Pritchard said: "This is the first drug to be repurposed through a world-leading new programme to help us realise the full potential of existing medicines to save and improve lives." Baroness Delyth Morgan, of charity Breast Cancer Now, called the roll-out a "major step forward". Baroness Delyth Morgan, chief executive at the charity Breast Cancer Now, said: "[It] will enable more eligible women with a significant family history of breast cancer to reduce their chance of developing the disease." The treatment is taken as a 1mg tablet, once a day for five years.

(4º§) Trials have shown that the drug reduces breast cancer cases by 49 per cent over 11 years among eligible women. The most common side effects of the medicine are hot flushes, feeling weak, pain/stiffness in the joints, arthritis, skin rash, nausea, headache, osteoporosis, and depression. The cases prevented by anastrozole could save the NHS £15 million in treatment costs.

(5º§) Around 47,000 women in England are diagnosed with breast cancer each year. Health Minister Will Quince said: "Breast cancer is the most common cancer in the UK so I'm delighted that another effective drug to help to prevent this cruel disease has now been approved. "We've already seen the positive effect anastrozole can have in treating the disease when it has been detected in post-menopausal women and now we can use it to stop it developing at all in some women." 


https://www.thesun.co.uk/health/24652823/nhs-offer-anastrozole-breast -cancer/ 
What is the main purpose of repurposing the drug Anastrozole according to the text?
Alternativas
Q3669322 Inglês
O texto seguinte servirá de base para responder à questão.


Haverá em breve uma vacina contra o câncer?


Empresas de biotecnologia querem lançar em alguns anos imunizantes contra a doença, algo que se tornou possível com a tecnologia de mRNA. Com isso, o câncer pode deixar de ser uma "sentença de morte". Em poucos anos, a tecnologia de RNA mensageiro (mRNA) revolucionou a medicina. Durante a pandemia de covid-19, imunizantes de alta eficácia contra o vírus Sars-Cov-2 foram desenvolvidos em apenas alguns meses graças a essa tecnologia.


Mesmo que o vírus se desenvolva com mutações mais agressivas, vacinas sob medida podem ser novamente desenvolvidas em pouco tempo graças à tecnologia de mRNA. Mas esse avanço, recentemente agraciado com o Prêmio Nobel de Medicina, pode ainda alcançar muito mais. 


A tecnologia de mRNA também deu novo impulso à pesquisa sobre o câncer. O CEO da empresa de biotecnologia CureVac, Alexander Zehnder, quer introduzir no mercado vacinas com base nessa tecnologia em um prazo máximo de cinco anos.


O desenvolvimento de vacinas contra certos tipos de câncer seria um sonho realizado para a humanidade. "Pesquisas sobre vacinas contra o câncer vêm sendo realizadas há 20 anos. Os progressos atuais, porém, são enormes", afirma Zehnder. "Ganhamos muita experiência durante a pandemia e a inteligência artificial está tão avançada que consegue resolver muitos problemas na programação do mRNA", explicou o chefe da CureVac em entrevista ao jornal alemão Bild am Sonntag.


As vacinas contra o câncer estimulam o sistema imunológico de maneira que as defesas próprias do corpo podem combater especificamente as células tumorais. "O fator mortal no câncer é o fato de ele se manter em crescimento. A vacina visa conter esse crescimento, mesmo que o câncer já esteja metastático. O câncer, dessa forma, se torna uma doença crônica com a qual se pode conviver durante décadas. Não é mais uma sentença de morte", disse Zehnder.


Corrida pela vacina


Além da CureVac, outras empresas também investem intensamente em pesquisas contra o câncer. No início de outubro, a empresa BioNTech publicou resultados preliminares promissores de um estudo clínico em andamento. A eficácia de sua vacina de mRNA contra o câncer, CARVac, já está sendo testada em cobaias.


O CEO da BioNTech, Ugur Sahin, disse em entrevista à revista alemã Der Spiegel que, segundo sua estimativa, haverá vacinas contra o câncer disponíveis nos próximos anos. "Acreditamos que será possível produzi-las em larga escala antes de 2030", afirmou.


No longo prazo, as vacinas tendem a substituir o tratamento convencional contra o câncer. Isso também seria um fator bastante positivo, uma vez que as terapias com quimioterapia ou radiação são extremamente agressivas para os pacientes.


"A quimioterapia ou a radiação nunca combatem somente o tumor, mas também os tecidos saudáveis. É por isso que há tantos efeitos colaterais", explicou Zehnder. "A vantagem de usar o mRNA é que o sistema imunológico próprio é estimulado e combate especificamente o câncer, e nada mais".


Como funciona a vacina?


As células T, ou linfócitos T, ajudam o corpo a combater infecções ao destruir as células adoecidas ou estimular outras células imunológicas a agirem, mas têm dificuldades em reconhecer as células cancerígenas, o que as células CAR-T conseguem fazer.


O tratamento com as células CAR-T foi aprovado na Europa em 2018 e vem sendo utilizado principalmente no tratamento da leucemia, o chamado câncer sanguíneo.


No entanto, essa forma bastante eficaz de imunoterapia tem custos impraticáveis para muitos. Segundo o Centro Alemão de Pesquisas sobre o Câncer da Alemanha, os fabricantes cobram até 320 mil euros pela produção dessas células imunológicas para apenas um paciente.


Nesse tipo de imunoterapia, as células T são filtradas dos leucócitos - os glóbulos brancos - do sangue do paciente. Elas então são geneticamente modificadas para formarem receptores quiméricos de antígeno (CARs) na superfície. Isso resulta em um receptor cujos componentes diferentes não se encaixam.


Vacinas deixam as células tumorais visíveis


Se as células CAR-T produzidas dessa forma forem injetadas de volta no paciente, elas se alojam especificamente nas células cancerígenas. O sistema imunológico é ativado e ataca as células tumorais. As futuras vacinas podem dar apoio a esse processo se, por exemplo, as células CAR-T não conseguirem encontrar ou estiverem muito enfraquecidas para lutar contra as tumorais.


Para deixar as células tumorais mais visíveis, a proteína Claudin-6 é introduzida na célula cancerígena com ajuda da tecnologia mRNA. Isso cria um antígeno que se aloja na superfície da célula tumoral, tornando-a mais fácil de ser reconhecida e combatida pelas CAR-T.


Até agora, as células T modificadas combatiam somente o câncer sanguíneo. Mas os avanços rápidos na tecnologia de mRNA aumentam as esperanças de que possa haver no futuro terapias eficazes e menos agressivas, não apenas para a leucemia, mas também para outros tipos de câncer.


Retirado e adaptado de: TERRA. Haverá em breve uma vacina contra o câncer? Portal Terra. Disponível em: https://www.terra. com.br/noticias/havera-em-breve-uma-vacina-contra-o-cancer, 60f8d40daa34735e8fe2882052bb273fti7x3zb1.html Acesso em: 09 nov., 2023.
Partindo da leitura do texto "Haverá em breve uma vacina contra o câncer?", analise as afirmações a seguir:

I.O tratamento com as células CAR-T foi iniciado durante a pandemia e resultou em muito conhecimento construído sobre o tema.
II.As células T já são empregadas no tratamento do câncer sanguíneo e, com o avanço da tecnologia, poderão ser empregadas também no combate de outros tipos de cânceres.
III.A única limitação apresentada pela tecnologia de mRNA é relativa às mutações possíveis nos vírus.
IV.A estimativa é que as vacinas substituam o tratamento convencional contra câncer nos próximos cinco anos.
V.Os tratamentos convencionais têm, como ponto negativo, a falta de especificidade de sua ação: além de destruir células cancerígenas, também acabam incidindo sobre células saudáveis.

É correto o que se afirma em:
Alternativas
Q3668621 Inglês
Considering the many uses for -ing forms, mark the option in which the -ing form is used as an adjective: 
Alternativas
Q3668620 Inglês
Concerning the title of the last text, the underlined word in “As few as 4,000 steps a day can reduce your risk of death, but more is better.” is classified as a/an:
Alternativas
Q3668619 Inglês
In English grammar, subordinating conjunctions are used to connect dependent clauses to independent clauses, adding more complexity to the sentences. These conjunctions tend to give more details about the main sentence, adding characteristics such as time, condition and cause. Considering that, read the following sentence and mark the alternative that contains the word that works as a subordinator and its meaning, respectively:

Exercise directly conditions the cardiovascular system, whereas benefit to other systems or conditions is somewhat less direct
Alternativas
Q3668618 Inglês
As few as 4,000 steps a day can reduce your risk of death, but more is better
By Sandee LaMotte, CNN Published 7:05 PM EDT, Tue August 8, 2023 Walking a minimum of 4,000 steps a day significantly reduces your risk of an early death, while taking 2,337 steps a day will reduce your risk of death specifically from cardiovascular disease but “more is better,” according to a new meta-analysis of studies. “The more steps you walk, the better the effects on your health, and every increase of steps by 500-1000 steps/day may be associated with significant mortality reductions,” first author Dr. Maciej Banach, deputy editor-in-chief of the European Society of Cardiology, said in an email. Anything below 5,000 steps a day is considered a “sedentary lifestyle,” according to the study. The fact that it takes fewer steps to reduce risk of cardiovascular disease is not surprising, said Dr. David Katz, a specialist in preventive and lifestyle medicine who was not involved in the study. “Exercise directly conditions the cardiovascular system, whereas benefit to other systems or conditions is somewhat less direct,” said Katz, president and founder of the nonprofit True Health Initiative, a global coalition of experts dedicated to evidence-based lifestyle medicine. The study’s methods were “robust and state of the art,” and support what doctors often tell their patients, Katz said. “First, any exercise is better than none — with significant cardiovascular and overall health benefit at quite modest levels,” he added. “And for the range of activity that pertains to the public at large — the more, the better!”
(Adapted from www.cnn.com)
In the text, the author uses both direct and reported speeches throughout the paragraphs. Indicate which one of the options below uses the direct speech to express an idea. 
Alternativas
Respostas
9721: A
9722: B
9723: C
9724: A
9725: E
9726: A
9727: A
9728: C
9729: B
9730: B
9731: D
9732: A
9733: D
9734: B
9735: C
9736: D
9737: B
9738: A
9739: B
9740: B